ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

TACE With Immune Agents for Angiogenesis in Hepatocellular Carcinoma

The First Hospital of Hebei Medical University · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
hepatocellularcarcinomananivolumab
hepatocellular carcinoma (hcc), tace, immune agents, hepatic arterial infusion, hepatocellular carcinoma, tumor angiogenesis, nivolumab, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 979706
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.